SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036167
Filing Date
2020-08-04
Accepted
2020-08-04 17:00:16
Documents
71
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q myok-10q_20200630.htm   iXBRL 10-Q 2424476
2 EX-10.1 myok-ex101_112.htm EX-10.1 56037
3 EX-10.2 myok-ex102_113.htm EX-10.2 19003
4 EX-31.1 myok-ex311_8.htm EX-31.1 15757
5 EX-31.2 myok-ex312_10.htm EX-31.2 15843
6 EX-32.1 myok-ex321_9.htm EX-32.1 8704
  Complete submission text file 0001564590-20-036167.txt   8052632

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA myok-20200630.xsd EX-101.SCH 47649
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myok-20200630_cal.xml EX-101.CAL 52929
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myok-20200630_def.xml EX-101.DEF 130095
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20200630_lab.xml EX-101.LAB 352089
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20200630_pre.xml EX-101.PRE 273119
12 EXTRACTED XBRL INSTANCE DOCUMENT myok-10q_20200630_htm.xml XML 1558417
Mailing Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 650-741-0900
MyoKardia, Inc. (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37609 | Film No.: 201074067
SIC: 2834 Pharmaceutical Preparations